SenzaGen
Henrik Johansson has more than 10 years of experience of research and development within the fields of cell and molecular biology. He is specialized in in vitro assays for predictive immunotoxicology and is a co-developer of the GARD technology platform, which was first described in detail in his doctoral thesis.
This person is not in any offices
SenzaGen
SenzaGen is a Swedish in vitro test lab company which offers animal-free testing of chemical compounds using genomics-based methodology for immunotoxicological assays. Its proprietary lead product family, GARD, potentially replaces the need for animal testing in the cosmetic, chemical and pharmaceutical industries.